Furthermore, diagnostic models leveraging either TREM2 or TIMD4 as biomarkers made remarkable diagnostic accuracy in NASH, underscoring their potential clinical utility. The gene discussed is TREM2; the disease is metabolic dysfunction-associated steatohepatitis.